Martine A. Rothblatt serves as Executive at UNITED THERAPEUTICS Corp, where they oversee executive responsibilities. Since joining the company, Martine A. Rothblatt has executed 4994 insider transactions totaling $1.1B, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 27, 2024 involved selling 31 shares valued at $7.4K.
Martine A. Rothblatt currently holds 130 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martine A. Rothblatt has been a net seller of UTHR stock. They have purchased $15.1M and sold $1.0B worth of shares.
Martine A. Rothblatt's most recent insider trade was on Mar 27, 2024, when they sold 31 shares at $237.15 per share.
Get notified when new Form 4 filings are submitted
| $129.49 |
| Planned |
| Mar 27, 2024 | UTHR | $492 | Sale | 2 | $246.24 | Planned |
| Mar 26, 2024 | UTHR | $122.2K | Sale | 496 | $246.46 | Planned |
| Mar 26, 2024 | UTHR | $35.2K | Sale | 144 | $244.67 | Planned |
| Mar 26, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| Mar 26, 2024 | UTHR | $1.1M | Sale | 4,366 | $248.42 | Planned |
| Mar 26, 2024 | UTHR | $1.5M | Sale | 5,926 | $247.63 | Planned |
| Mar 26, 2024 | UTHR | $111.3K | Sale | 444 | $250.64 | Planned |
| Mar 26, 2024 | UTHR | $904.1K | Sale | 3,624 | $249.48 | Planned |
| Mar 25, 2024 | UTHR | $149.8K | Sale | 603 | $248.49 | Planned |
| Mar 25, 2024 | UTHR | $205.3K | Sale | 829 | $247.59 | Planned |
| Mar 25, 2024 | UTHR | $125.5K | Sale | 509 | $246.57 | Planned |
| Mar 25, 2024 | UTHR | $122.9K | Sale | 502 | $244.88 | Planned |
| Mar 25, 2024 | UTHR | $713.2K | Sale | 2,924 | $243.90 | Planned |
| Mar 25, 2024 | UTHR | $1.0M | Sale | 4,252 | $243.09 | Planned |
| Mar 25, 2024 | UTHR | $828.3K | Sale | 3,421 | $242.12 | Planned |
| Mar 25, 2024 | UTHR | $359.6K | Sale | 1,492 | $241.05 | Planned |
| Mar 25, 2024 | UTHR | $112.1K | Sale | 468 | $239.60 | Planned |
| Mar 25, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| Mar 22, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| Mar 22, 2024 | UTHR | $1.2M | Sale | 5,212 | $237.56 | Planned |
| Mar 22, 2024 | UTHR | $417.6K | Sale | 1,780 | $234.62 | Planned |
| Mar 22, 2024 | UTHR | $173.0K | Sale | 735 | $235.34 | Planned |
| Mar 22, 2024 | UTHR | $854.7K | Sale | 3,612 | $236.62 | Planned |
| Mar 22, 2024 | UTHR | $872.4K | Sale | 3,661 | $238.29 | Planned |
| Mar 21, 2024 | UTHR | $592.7K | Sale | 2,497 | $237.38 | Planned |
| Mar 21, 2024 | UTHR | $317.1K | Sale | 1,353 | $234.38 | Planned |
| Mar 21, 2024 | UTHR | $1.9M | Option Exercise | 15,000 | $129.49 | Planned |
| Mar 21, 2024 | UTHR | $589.0K | Sale | 2,500 | $235.58 | Planned |